Overview A Study of GLWL-01 in Patients With Prader-Willi Syndrome Status: Completed Trial end date: 2019-06-12 Target enrollment: Participant gender: Summary The aim of this study is to evaluate efficacy, safety, and pharmacokinetics of GLWL-01 in the treatment of patients with Prader-Willi Syndrome (PWS). Phase: Phase 2 Details Lead Sponsor: GLWL Research Inc.